Mesa Laboratories
MLAB
65 hedge funds and large institutions have $158M invested in Mesa Laboratories in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 28 increasing their positions, 17 reducing their positions, and 6 closing their positions.
65% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $166M → $158M (-$7.7M)
2% less funds holding
Funds holding: 66 → 65 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$4.76M |
| 2 |
BCM
Bares Capital Management
Austin,
Texas
|
+$3.43M |
| 3 |
Renaissance Technologies
New York
|
+$2.19M |
| 4 |
Morgan Stanley
New York
|
+$1.08M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$241K |
Top Sellers
MLAB Hedge Fund Activity: Q2 2014 in Review
65 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2014, worth a combined $158M — down 4.7% from $166M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MLAB and 5 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 28 added.
The largest buyer was Conestoga Capital Advisors, adding an estimated $4.76M. The largest seller was Mawer Investment Management, exiting entirely with an estimated $3.84M sold.
- 65 institutional investors held Mesa Laboratories (MLAB) as of Q2 2014, down from 66 in Q1 2014.
- Funds reported $158M of Mesa Laboratories stock for Q2 2014, down 4.7% quarter-over-quarter.
- 5 funds opened new Mesa Laboratories positions in Q2 2014 and 6 closed out, a net change of -1 holder.
- The largest Mesa Laboratories buyer in Q2 2014 was Conestoga Capital Advisors, an estimated $4.76M added.
- The largest Mesa Laboratories seller in Q2 2014 was Mawer Investment Management, an estimated $3.84M sold.
Based on aggregated 13F filings for Q2 2014.